Navigation Links
Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Date:6/6/2008

"We are choosing not to advance the SYI-2074 program in the very competitive area of acute coronary syndrome at this time, in the absence of stronger surrogate markers of efficacy," said Noah Berkowitz, M.D., Ph.D., President and Chief Executive Officer of Synvista Therapeutics.

"We are pleased to have established correlation between increased plasma isoprostanes and haptoglobin type, as we believe this further validates the biology underlying our proprietary haptoglobin test. Haptoglobin typing has been used in studies that have evaluated more than 20,000 patients, and researchers have demonstrated that Hp2-2 patients with diabetes are at high risk for myocardial infarction, heart failure and stroke. To that end, our diagnostic test is on track to be available commercially in the second quarter of 2009. Further, we are planning to submit a kit measuring CML (carboxy-methyl-lysine), another increasingly well-validated, cardiovascular biomarker, for FDA marketing clearance in 2009," Dr. Berkowitz continued. "We are also moving forward with our alagebrium program, which began enrollment last month in a Phase 2 study for diastolic heart failure in Haptoglobin 2-2 diabetic patients, which complements a second Phase 2 study in systolic heart failure, begun last November and almost half enrolled."

About the Studies

Trial 201 was a Phase 2, placebo-controlled, dose-escalation study in which patients with diabetes and Hp2-2 were given SYI-2074 at 20, 40 or 80mg or placebo three times daily for 28 days. The study evaluated the impact of these doses on inflammatory biomarkers, and the quality and quantity of their cholesterol. Results found that SYI-2074 demonstrated improvement in some but not all of these biomarkers.

Trial 201a was a Phase 2, placebo-controlled sub-study of Trial 201. Patients with diabetes, meeting enrollment criteria for Trial 201 were tested for haptoglobin type. Patients with Hp2-2 or Hp1-1 were evaluated for baseline leve
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
2. Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure
3. Synvista Announces New Data Showing Haptoglobin Type Predicts Effectiveness of Tight Glycemic Control on Cardiovascular Outcomes in Patients with Diabetes
4. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
5. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
6. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. TorreyPines Therapeutics Initiates Clinical Trial to Evaluate Analgesic Effect of Oral Prodrug of Tezampanel
9. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
10. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
11. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 On ... ("Plaintiff") filed suit in the 116 th ... Texas , against RegenLab USA, LLC ... and Prospective Business Relationships through false and ... and, Business Disparagement through libel, disparagement, ...
(Date:7/23/2014)... 2014 Research and Markets   ... Electrophysiology Ablation Catheters Market 2014-2018" report to ... Catheter ablation is a minimally ... electrical pathways from sections of the heart that ... arrhythmias). Cardiac arrhythmias can be of several types, ...
(Date:7/23/2014)... Top Staten Island Pediatrician Dr. Michael Gabriel ... discusses tips for parents about pool safety for children. ... to US News article, "Drowning is the leading ... 1 to 4, and can occur in as little as ... article says that watching a child in the water every ...
Breaking Medicine Technology:Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Premier Staten Island Pediatrician Dr. Michael Gabriel Comments On Article Discussing Pool Safety Tips for Parents 2
... Ill., April 1, 2011 Hospira ... of clinical information and medication delivery technologies, today announced ... system , used by hospitals to help improve patient ... (HAIs). The enhanced TheraDoc system includes new features and ...
... & Dempsey is launching Accountable Care Forum - ... analysis of the emerging accountable care organization (ACO) landscape. ... Centers for Medicare & Medicaid Services (CMS). ... reform legislation affecting physicians and hospitals across the United ...
Cached Medicine Technology:Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care 2Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care 3Online Forum for Accountable Care Organization Developments Launches Today; Squire Sanders Sponsorship Reflects Commitment to Leadership in Emerging Health Policy Debate 2
(Date:7/23/2014)... July 23, 2014 Obtaining insurance information ... the average consumer. The Quotes Pros company is launching ... 50 states this year to make research faster at ... issuing the rates information are actual agencies that specialize ... inside the U.S. An advantage to adults who use ...
(Date:7/23/2014)... and young adults living near Sellafield or Dounreay since ... developing cancer according to research published in the ... from the Childhood Cancer Research Group at the University ... between 1963 and 2006 among those who were under ... No difference was found in cancer incidence from 1991-2006 ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014 In ... place Aug. 10-16, Millennium Treatment Group is providing tips ... has existed in society ever since man first figured ... Substance abuse treatment has existed since shortly thereafter. Its ... a problem and then developing a way to combat ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... powerful drug combo may not be as effective against ... human cells suggests that one of the medications might ... study,s findings aren,t definitive, and there,s still hope for ... lumacaftor, according to the study,s senior author. "The ...
(Date:7/23/2014)... NJ (PRWEB) July 23, 2014 Celebrating ... for New Jersey today announced the awarding of $1,070,000 ... a special award in recognition of the Foundation’s 1,000th ... proud to continue our tradition of supporting community-based organizations ... the quality of life in the Garden State,” said ...
Breaking Medicine News(10 mins):Health News:Term Life Insurance Prices for All 50 States Now Explored at Insurer Website 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5
... to tackle issue , , THURSDAY, March 26 (HealthDay ... to be tainted with traces of medications and common ... Environmental Protection Agency and Baylor University. , The common ... antidepressants were among the seven types of pharmaceuticals found ...
... Criteria include added section on hospital care and advice ... 26 (HealthDay News) -- New guidelines for treatment of ... Association and the American College of Cardiology, with a ... condition and also on the treatment of blacks. , ...
... - A one-of-a-kind graduate program that focuses on the ... at The University of Texas M. D. Anderson Cancer ... The University of Texas System. , The Graduate Program ... on understanding and attacking the spread of cancer from ...
... This release is available in French . ... Africa increases, so does the need for improved review of ... work on increasing the quality of research, we should also ... established National Bioethics Committee of Gabon, which was established with ...
... Contender, Nate "The Great" Marquardt, Joins the Growing List of ... , ... Denver, CO (PRWEB) March ... title contender, Nate "The Great" Marquardt, recently underwent successful PRK ...
... annually, according to Millennium Research GroupWALTHAM, Mass., March ... US Markets for Large-Joint Reconstructive Implants 2009 ... segment of the large-joint reconstructive implant market through ... of over 25%. Hip resurfacing is championed ...
Cached Medicine News:Health News:Fish in U.S. Rivers Tainted With Common Medications 2Health News:New Guidelines for Treating Heart Failure 2Health News:New Guidelines for Treating Heart Failure 3Health News:M. D. Anderson launches graduate program in cancer metastasis 2Health News:Gabon establishes national ethics committee 2Health News:Ultimate Fighting Championship Title Contender Joins the List of Professional Athletes Choosing Denver's Icon LASIK for Laser Vision Correction 2Health News:Ultimate Fighting Championship Title Contender Joins the List of Professional Athletes Choosing Denver's Icon LASIK for Laser Vision Correction 3Health News:Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement 2Health News:Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement 3
... Variable cutting speeds (guillotine movements) are ... when switched off, thus minimizing tissue trauma. ... action, or both can be combined together. ... uni or bi-manual techniques. Lightweight autoclavable hand-pieces ...
...
...
LASIK Retreatment Forceps - Also available in Titanium...
Medicine Products: